👏 Congratulations to all those who participated in the Great North Run yesterday, including our very own Sophie Fanthorpe, raising money for Marie Curie UK. A great day for the city of Newcastle and we look forward to seeing everyone in 2025. #GNR2024 #NorthEast
QuantuMDx
Biotechnology Research
Newcastle upon Tyne, Tyne and Wear 6,341 followers
Transforming Point of Need Multiplex Diagnostics
About us
QuantuMDx is a progressive MedTech company passionate about creating multiplex molecular diagnostic solutions for use at the point of need.
- Website
-
https://www.quantumdx.com/
External link for QuantuMDx
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Newcastle upon Tyne, Tyne and Wear
- Type
- Privately Held
- Founded
- 2008
- Specialties
- MedTech, Molecular Diagnostics, Multiplex Molecular Diagnostics, Point of Care, Point of Need, COVID-19, Medical device, Diagnostic device, DNA extraction, TB, Sepsis, Transcriptomics, PCR, Microarray, Assay Development, Assay Feasibility, Rapid Diagnostics, Respiratory Infections, Sexually Transmitted Infections, Host Response, and In vitro Diagnostics
Locations
-
Primary
Lugano Building, 57, Melbourne Street
Newcastle upon Tyne, Tyne and Wear NE1 2JQ, GB
-
Suite 205
Chattanooga, TN 37408, US
Employees at QuantuMDx
-
Paul J. Fitzpatrick
Entrepreneur | CEO | Fractional C-Level Leader | Board Director | Mentor
-
Jonathan O'Halloran
Chief Executive Officer at QuantuMDx Group Limited
-
Stephen Osborne
CEO, CSO & Founder at Pastel BioScience Limited
-
Matthew Bland
Senior Quality Control Officer at QuantuMDx Group Limited
Updates
-
"Antimicrobial resistance threatens the very core of modern medicine and the sustainability of an effective, global public health response to the enduring threat from infectious diseases." Here are five ways to tackle the issue of AMR according to the World Health Organization Global Action Plan. #AMR #AntimicrobialResistance #GlobalHealth
-
💕 Today is World Sexual Health Day (WSHD) and the theme this year is Positive Relationships. This day raises social awareness on sexual health and well-being, highlighting the importance of knowing your sexual health status. Regular testing for common sexually transmitted diseases promotes a safe and respectful environment in relationships. QuantuMDx are looking forward to launching a rapid, point of care test for the simulatneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Mycoplasma genitalium next year. Get in touch for more information at info@quantumdx.com #WSHD24 #SexualHealth #STI #POC
-
-
🥇 Our fantastic Senior QA Officer, Sophie Fanthorpe, is running the Great North Run for the first time this weekend. She is taking on the challenge to raise money for Marie Curie UK, in memory of her Dad. We are so proud of Sophie and wish her all the best for Sunday. 🔗 Link to her fundraising page is in the comments below, she would be grateful for any support to get her over the finish line! #GNR2024 #NorthEast #MarieCurie
-
-
Ahead of the ticket sale for #Oasis reunion tour tomorrow, we're looking back 30 years ago (9th Aug 1994) when the band performed at QuantuMDx HQ (previously the Riverside) on Melbourne Street in Newcastle! https://lnkd.in/egasXmTk
-
QuantuMDx reposted this
The Lusis Team had a great time at the #ADLM Clinical Lab Expo in Chicago. At our booth, we showcased the latest in molecular science, including our VeraPoint qPCR reagents and Q-Vera qPCR instruments. These innovations are designed to meet the evolving needs of laboratories by offering accuracy, affordability, and scalability across a wide range of infectious disease applications. Whether you stopped by to learn more about our products, take an alcohol tolerance test, or snag one of our virus plushies, we're grateful for your time and interest. Let's continue the conversation! Email us at sales@lusisbio.com to learn more about how Lusis products and services can support your needs. #ADLM2024 #ClinicalLabExpo #InfectiousDiseases #Innovation #PCR #LabTech
-
A report published yesterday by UK Health Security Agency has revealed that there were 15 new confirmed cases of infection with ceftriaxone-resistant Neisseria gonorrhoeae, including 5 which were extensively drug-resistant, detected in England between June 2022 and May 2024. N. gonorrhoeae, the causative agent of gonorrhoea, is becoming increasingly resistant to antibiotics and there is a significant risk that the disease could become untreatable in the future. Accessible and accurate testing for common sexually transmitted infections is vital for the detection and prevention of onward transmission and to preserve the efficacy of widely used antibiotics. Read the report here: https://lnkd.in/e9-AHFHZ #STI #RapidDiagnostics #AntimicrobialResistance #AMR #AntibioticStewardship
Case-series of ceftriaxone-resistant Neisseria gonorrhoeae infections detected in England
gov.uk
-
QuantuMDx reposted this
Another great trade show. Met lots of folks to discuss QuantuMDx point of care rapid multiplex diagnostic testing device, the QPOC. Looking for to next year.
Thank you to all those who came to visit the team in Chicago at Association for Diagnostics & Laboratory Medicine, we look forward to seeing you in the Windy City again next year. #ADLM2024 #AACC #RapidDiagnostics #LaboratoryMedicine
-
Thank you to all those who came to visit the team in Chicago at Association for Diagnostics & Laboratory Medicine, we look forward to seeing you in the Windy City again next year. #ADLM2024 #AACC #RapidDiagnostics #LaboratoryMedicine